CoChat

Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study

Catafau, Ana M., Perez, Victor, Plaza, Pedro, Pascual, Juan-Carlos, Bullich, Santiago, Suarez, Marina, Penengo, Maria M., Corripio, Iluminada, Puigdemont, Dolors, Danus, Monica, Perich, Javier, Alvarez, Enric · 2006 · Psychopharmacology

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Rationale To assess the paroxetine-induced serotonin transporter (SERT) occupancy (SERTocc) using in vivo (123)I-ADAM SPECT.Objectives (123)I-ADAM SPECT was used to investigate the SERTocc induced by paroxetine in major depression disorder (MDD) patients, to compare the SERT availability in drug-free MDD patients and healthy volunteers, and to study the relationship between paroxetine plasma concentrations (Cp) and SERTocc.Materials and methods Measures of SERT availability by means of (123)I-ADAM SPECT were obtained in ten MDD patients before and after 4- to 6-week treatment with paroxetine 20 mg/day. (123)I-ADAM SPECT measures of SERT availability from a group of ten previously studied age-matched healthy volunteers were used for comparison. The relationship between percentages of SERTocc and paroxetine Cp was studied using an E (max) model.Results Mean SERTocc values were 66.4 +/- 9.5% in midbrain, 63.0 +/- 9.6% in thalamus, and 61.3 +/- 10.9% in striatum. No significant differences in SERTocc were found among these three regions. No significant differences in mean SERT availability were found in any region between drug-free MDD patients (midbrain = 1.14 +/- 0.15; thalamus = 0.85 +/- 0.13; striatum = 0.70 +/- 0.07) and healthy volunteers (midbrain = 1.19 +/- 0.22; thalamus = 0.96 +/- 0.14; striatum = 0.67 +/- 0.15). The E (max) model returned a SERTocc(max) = 70.5% and a Cp(50) = 2.7 ng/ml.Conclusions Using (123)I-ADAM SPECT, treatment with paroxetine 20 mg/day leads to more than 60% SERTocc on average in cerebral regions with known high SERT density. Data from this study do not support the existence of SERT availability differences between drug-free MDD patients and healthy volunteers. Finally, the E (max) model is suitable for the study of paroxetine Cp relationship to (123)I-ADAM SPECT-measured SERTocc. This approach may be useful for pharmacokinetic-pharmacodynamic relationships in drug development.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-006-0540-y

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Ahonen A, Heikman P, Kauppinen T, Koskela A, Bergström K (2004) Serotonin transporter availability in drug free depression patients using a novel SERT ligand. Eur J Nucl Med 31:S227

Cited by

See all 46

Metadata

Authors
Catafau, A. M., Perez, V., Plaza, P., Pascual, J.-C., Bullich, S., Suarez, M., Penengo, M. M., Corripio, I., Puigdemont, D., Danus, M., Perich, J., & Alvarez, E.
Affiliations
  • GlaxoSmithKline (Spain) (ES)
  • Hospital Del Mar (ES)
  • Hospital de Sant Pau (ES)
Corresponding author
Catafau, Ana M.
Venue
Psychopharmacology
Published
2006-10-11
Volume
189
Issue
2
Pages
145-153
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2013861319
Cited by
46
References
35
Citations by year
2023: 1 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 1 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 4
FWCI
1.90
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
paroxetine, plasma drug concentration, Emax model, midbrain, thalamus, striatum, healthy volunteers comparison
MeSH terms
Adult, Brain, Cinanserin, Corpus Striatum, Depressive Disorder, Female, Humans, Iodine Radioisotopes, Male, Mesencephalon, Middle Aged, Radioligand Assay, Serotonin Antagonists, Thalamus, Tomography, Emission-Computed, Single-Photon, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Serotonin Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. https://app.cochat.ai/papers/10.1007/s00213-006-0540-y
The paper
Catafau, A. M., Perez, V., Plaza, P., Pascual, J.-C., Bullich, S., Suarez, M., Penengo, M. M., Corripio, I., Puigdemont, D., Danus, M., Perich, J., & Alvarez, E. (2006). Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. Psychopharmacology. https://doi.org/10.1007/s00213-006-0540-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.